Walleye Capital’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.41M | Sell |
81,270
-236,172
| -74% | -$4.09M | 0.01% | 731 |
|
|
2025
Q1 | $6.94M | Sell |
317,442
-77,381
| -20% | -$1.69M | 0.03% | 287 |
|
|
2024
Q4 | $12.6M | Buy |
394,823
+292,743
| +287% | +$9.34M | 0.03% | 214 |
|
|
2024
Q3 | $2.94M | Buy |
102,080
+51,441
| +102% | +$1.48M | 0.01% | 609 |
|
|
2024
Q2 | $1.94M | Sell |
50,639
-60,160
| -54% | -$2.31M | ﹤0.01% | 828 |
|
|
2024
Q1 | $6.51M | Sell |
110,799
-36,875
| -25% | -$2.17M | 0.01% | 362 |
|
|
2023
Q4 | $8.84M | Buy |
147,674
+13,691
| +10% | +$820K | 0.02% | 225 |
|
|
2023
Q3 | $5.1M | Buy |
133,983
+76,074
| +131% | +$2.89M | 0.01% | 385 |
|
|
2023
Q2 | $5.28M | Sell |
57,909
-61,469
| -51% | -$5.6M | 0.02% | 283 |
|
|
2023
Q1 | $7.87M | Buy |
+119,378
| New | +$7.87M | 0.12% | 183 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 2118 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 2264 |
|
|
2022
Q2 | – | Sell |
-12,687
| Closed | -$645K | – | 2278 |
|
|
2022
Q1 | $645K | Sell |
12,687
-102,446
| -89% | -$5.21M | 0.02% | 842 |
|
|
2021
Q4 | $5.44M | Buy |
+115,133
| New | +$5.44M | 0.17% | 121 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 600 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 527 |
|